Abstract
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited disease characterized by left ventricular hypertrophy, progressive diastolic dysfunction, left ventricular outflow obstruction, ventricular arrhythmias, and sudden death. Due to widespread screening and early diagnosis, there is a growing number of women of reproductive age with HCM who become pregnant. Despite this trend, there is limited clinical evidence addressing the challenges of diagnosis, risk stratification, and management of HCM. Observational studies have suggested that HCM is generally well tolerated during pregnancy, with many women experiencing normal pregnancy and delivery outcomes. However, complications may arise in some cases, necessitating consideration of advanced therapeutic interventions before pregnancy. This review will examine the epidemiology, clinical presentation, diagnosis, and management of HCM during pregnancy.